The BRICS Cancer Therapeutics Market Outlook (2021-2031) reflects a rapidly expanding healthcare sector driven by rising cancer incidence, improving medical infrastructure, and increasing access to advanced treatment options. The BRICS nations—Brazil, Russia, India, China, and South Africa—are experiencing a growing burden of cancer due to aging populations,...
According to a newly published market research report by 24LifeSciences, the global Epidermal Growth Factor (EGF) Antibody market was valued at USD 323.5 million in 2023 and is projected to reach USD 625.4 million by 2030, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period 20242030.
Epidermal Growth Factor (EGF) antibodies, ranging from monoclonal to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek